Effect of Milk Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Children With Autism

Completed · Not applicable

Conditions studied: Autism

In brief

The purpose of this study is to determine the tolerability of dietary supplements and if these supplements can promote a healthy bacterial environment in the intestines of children with autism spectrum disorders and gastrointestinal complaints.

Key facts

Study ID

NCT02086110

Run by

University of California, Davis

People needed

11

Starts

2014-06-06

Expected to finish

2015-11-16

Last updated by the study team

2019-08-01

Who can join

Age: 2 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Autism
• Diarrhea and/or constipation

You may not qualify if…

• Milk protein or other documented food allergy
• Lactose intolerance
• Compromised Immunity
• GI conditions (inflammatory bowel disease, celiac disease, short gut, etc.)
• Systemic steroid, antifungal, or antibiotic use within a month of starting the study
• Failure to thrive
• Medically prescribed diets or supplements (including probiotic use within the past month).
• Vegetarian or dairy restricted diet
• Other medical conditions (seizures, genetic disorders, liver/pancreatic disease, cystic fibrosis, etc.)
• Medications that interfere or alter intestinal motility or microbiota composition.
• Full scale intelligence quotient (IQ) <40

Where it is running

• UC Davis MIND Institute — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.